PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Techdow Pharma England Ltd
TP

Techdow Pharma England Ltd

Guildford
Large

Techdow Pharma England Ltd is part of a global organization that specializes in medicines for managing and treating conditions caused by blood clots, such as venous thromboembolism, deep vein thrombosis, and pulmonary embolism.

techdow-pharma.co.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£420.0m
Live
7
Buyers
5
12m
£321.3m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities5
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts7 / 20
  • Top buyers5
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Techdow Pharma England LtdUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Techdow Pharma England Ltd has won £420.0m across 5 public-sector buyers, with 7 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 99% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
7 of 20Live contracts
99%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

⚑ Self-reported & from notices

Service tags, sectors served and target geographies appear here once a supplier verifies ownership of this profile.

Frameworks & DPS · 5 from notices
  • NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England · £13.3m
  • NHS England - Midlands and East Branded Medicines - Tranche BNHS England · £9.2m
  • NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder OpportunityNHS England · £8.4m
  • NHS Framework Agreement - North of England - Tranche BNHS England · £5.6m
  • Supportive Medicines including ITU, EOL & AntibioticsDepartment of Health and Social Care (T&T) · £1.7m

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 7 live · 13 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS England—01 Mar 2026£321.3m2 yrspending
CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins
NHS England3360000001 Sept 2023£23.3m2 yrsClosed
NHS Framework Agreement, Branded Medicines for London and South of England
NHS England3360000001 Sept 2021£13.3m2 yrsClosed
NHS Framework for the Midlands and East, Branded Medicines - Tranche B
NHS England3360000001 Mar 2021£6.2m2 yrsClosed
Supportive Medicines including ITU, EOL & Antibiotics
Department of Health and Social Care (T&T)3360000017 Sept 2020£1.7m11 moClosed
Supportive Medicines including ITU, EOL & Antibiotics
Department of Health and Social Care (T&T)3360000017 Sept 2020£1.7m11 moClosed
Supportive Medicines including ITU, EOL & Antibiotics
Department of Health and Social Care (T&T)3360000017 Sept 2020£1.7m11 moClosed
NHS Framework Agreement - North of England - Tranche B
NHS England3360000001 Mar 2020£5.6m2 yrsClosed
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
NHS England3360000001 Sept 2019£8.4m12 moClosed
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England3360000001 Mar 2019£9.2m2.1 yrsClosed
Total live value — · mean award £21.0m1–10 of 20

Top buyers · 5 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
13 contracts
99%
since 2019
2
Department of Health and Social Care (T&T)
3 contracts
1%
since 2020
3
Procurement and Logistics Service, Business Services Organisation
1 contract
0%
4
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
2 contracts
0%
5
The NHS Commissioning Board (operating under the name of NHS England)
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire13 contracts
100%
Northern Ireland1 contract
0%
Scotland2 contracts
0%
North West1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Techdow Pharma England Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
TP
Techdow Pharma England Ltd
No£321.3m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 19 Dec 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
10513412
Status
Active
Type
Private limited
Incorporated
06 Dec 2016
Reg. office
Surrey Technology Centre Surrey Research Park, 40 Occam Road, Guildford, GU2 7YG
SIC codes
46460
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • CHEN, Juan — director
    Appointed 01 May 2024
  • GEORGE, Paula — director
    Appointed 01 Mar 2023
  • Techdow Pharma Netherlands Bv — person with significant control
    significant influence or control

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
TECHDOW PHARMA ENGLAND LIMITED
10513412 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.